prof. dr. Bart Vandekerckhove
- ORCID iD
-
0000-0003-3828-4195
Show
Sort by
-
- Journal Article
- A1
- open access
Cationic mRNA lipid nanoparticles for ex vivo NanoCAR‐T cell engineering
-
- Journal Article
- A1
- open access
A platform for high-throughput and ultrasensitive immunopeptidomics
-
Phase Ia study of MIDRIX4-LUNG, a tetravalent autologous dendritic cell immunotherapy, in patients with metastatic non-small cell lung cancer
-
- Journal Article
- A1
- open access
Gentle and efficient engineering of primary human NK cells by photoporation with polydopamine nanosensitizers
-
Cell surface proteomics of patient-derived malignant rhabdoid tumor organoids identifies ROBO1 as potential CAR T cell target for pediatric solid tumors
-
- Journal Article
- A1
- open access
Cracking rare disorders : a new minimally invasive RNA-seq protocol
-
- Journal Article
- A1
- open access
Preclinical toxicological assessment of an α-galactosylceramide-adjuvanted mRNA cancer vaccine in Wistar Han rats and domestic pigs
-
Photothermal nanofiber-mediated photoporation for gentle and efficient intracellular delivery of macromolecules
-
- Journal Article
- A1
- open access
Photoporation of NK-92MI cells with biodegradable polydopamine nanosensitizers as a promising strategy for the generation of engineered NK cell therapies
-
- Journal Article
- A1
- open access
ThymoSpheres culture : a model to study human polyclonal unconventional T cells